Effects of Saccharomyces boulardii in children with acute diarrhoea
about
sameAs
Probiotics for treating acute infectious diarrhoeaProbiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparationsThe role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsProbiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseasesThe use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American expertsClinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infectionProbiotics, enteric and diarrheal diseases, and global health.Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children.Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.Some current applications, limitations and future perspectives of lactic acid bacteria as probioticsIntestinal microbiota and health in childhood.Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.Probiotics to prevent the need for, and augment the use of, antibiotics.Probiotics in paediatric gastrointestinal diseases.Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects.Probiotics in clinical practice: an overview.Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.Antimicrobial and probiotic properties of yeasts: from fundamental to novel applicationsProbiotics and prebiotics in pediatric diarrheal disorders.Saccharomyces boulardii CNCM I-745 in different clinical conditions.Comparison of three patterns of feed supplementation with live Saccharomyces cerevisiae yeast on postweaning diarrhea, health status, and blood metabolic profile of susceptible weaning pigs orally challenged with Escherichia coli F4ac.Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.Comparison of efficacy of Saccharomyces boulardii strain in the treatment of acute diarrhea in children: A prospective, single-blind, randomized controlled clinical trialOral consumption of potential probiotic Saccharomyces boulardii strain Unique 28 in patients with acute diarrhoea: a clinical report.Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study.Parental management of childhood diarrhea.Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants.Immunological and central nervous system changes in mice suffering from Staphyloccocus aureus and treated with Saccharomyces cerevisiae var. vini living cells.
P2860
Q24236704-5A5ECA01-D674-44B0-B44C-56EEF5AF6E8DQ24679315-9FA4D4BB-9850-4893-AE00-B42C7509CA41Q26739291-87AAD663-81D7-4C75-AF58-C224AF813417Q26800020-0D837FA5-6354-4DF7-BB8D-2248DE954609Q26823347-616356F4-5AFD-4904-BE74-493B3B974F44Q28294880-BAC7E271-FDE8-4F74-A3E2-1A4A4F21F6C3Q30425561-C8AAB306-5B1F-4983-A1F2-A8AAFF05344FQ33671587-0D1E6A0C-B21D-4031-8BCE-1CCD44DDAAD8Q33693688-5AC20173-F9EB-45B0-B50E-F17148BB9977Q33810967-B39D9B64-60BA-4817-8A28-34F16FC885E0Q33920563-B48290C4-EBD9-48E5-8044-A55A1499A036Q34159275-130AADFE-A498-40D6-ADF8-A6D0F658403DQ34497819-8B1C18FE-4418-43FC-9073-9DDF5E881EBAQ36171266-42E3B1E8-C01B-4BDC-BA85-6898A9DECCFEQ36816072-13AADF76-B0A9-4D4F-A5AC-ADC051727C01Q36824470-77E38F7B-9204-4EA2-81A0-09A587BC2096Q37071265-0472FA17-5CD2-40B4-90C2-0E9D9393FCB5Q37994188-0E3A1E2D-10AD-4FBA-AC35-84542AA7DB06Q38069827-59C8E026-CC58-4649-AABE-2E53CB8C6712Q38081229-217717D9-2AB0-4F56-B516-C80ED029FA7CQ38226331-E33321D0-B7F3-4122-8790-BF1DD5E54F44Q41198017-9E4DB9F6-F30A-4DF7-B570-72C6CC73521CQ41502760-70433ADB-3D56-41A0-95F5-7CA5EED79F50Q41677313-75BD03D0-AA59-40E1-A6FB-504962684B3BQ41981140-06AC6AAF-8775-42EA-8537-8AB95D97E164Q43342558-C8D56B1B-E7B9-409A-BFBF-E19F9C6C5D07Q46087545-A5E269F0-95BF-44E4-870A-CAAA399C38D4Q46632194-31952DB1-19A5-4803-AA5B-CB3AB97C93B6Q47288433-2CE94F48-4148-412C-A1BB-D223B4691FADQ48190095-CE49DCCA-ABCC-4C21-9157-C1FA3A34D704
P2860
Effects of Saccharomyces boulardii in children with acute diarrhoea
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effects of Saccharomyces boulardii in children with acute diarrhoea
@ast
Effects of Saccharomyces boulardii in children with acute diarrhoea
@en
Effects of Saccharomyces boulardii in children with acute diarrhoea
@nl
type
label
Effects of Saccharomyces boulardii in children with acute diarrhoea
@ast
Effects of Saccharomyces boulardii in children with acute diarrhoea
@en
Effects of Saccharomyces boulardii in children with acute diarrhoea
@nl
prefLabel
Effects of Saccharomyces boulardii in children with acute diarrhoea
@ast
Effects of Saccharomyces boulardii in children with acute diarrhoea
@en
Effects of Saccharomyces boulardii in children with acute diarrhoea
@nl
P2093
P3181
P1433
P1476
Effects of Saccharomyces boulardii in children with acute diarrhoea
@en
P2093
G Koturoğlu
G. Koturoğlu
Z. Kurugöl
P3181
P356
10.1080/08035250410022521
10.1111/J.1651-2227.2005.TB01786.X
P407
P577
2005-01-01T00:00:00Z